Axe Compute Lists on NASDAQ as Enterprise Decentralized AI Compute Provider

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
Axe Compute, formerly Predictive Oncology, began trading on NASDAQ under the ticker AGPU. The firm will commercialize Aethir’s decentralized GPU network, offering on-chain analysis for enterprise AI clients. Supported by the Aethir Strategic Compute Reserve, the company aims to meet demand for GPU reservations, dedicated clusters, and SLA contracts. Aethir operates over 435,000 GPU containers globally, featuring top-tier hardware like NVIDIA H100 and B300. This listing marks the first U.S.-listed decentralized GPU infrastructure entering the enterprise market.

Derived from PANews, Predictive Oncology has rebranded as Axe Compute and begun trading on NASDAQ under the ticker AGPU. The company will commercialize Aethir's decentralized GPU network, offering enterprise-grade computing services to AI firms. Axe Compute's enterprise compute business will be supported by Aethir Strategic Compute Reserve, aiming to fulfill enterprise demands for GPU reservations, dedicated clusters, bare-metal performance, multi-region deployment, and SLA contracts. Aethir currently operates over 435,000 GPU containers across 93 countries and 200+ regions, supporting high-end hardware like NVIDIA H100, H200, B200, and B300. Axe Compute's listing marks the first time a decentralized GPU infrastructure has entered the mainstream enterprise market as a U.S.-listed company.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.